Our Terms of Service and Privacy Policy have changed.

By continuing to use this site, you are agreeing to the new Privacy Policy and Terms of Service.

Neogenomics Inc (NASDAQ:NEO)

9.25
Delayed Data
As of Jul 25
 -0.06 / -0.64%
Today’s Change
5.26
Today|||52-Week Range
9.54
+17.53%
Year-to-Date

Today’s Trading

Previous close9.31
Today’s open9.29
Day’s range9.00 - 9.35
Volume421,040
Average volume (3 months)462,438
Market cap$713.3M
Dividend yield--
Data as of 07/25/2016

Growth & Valuation

Earnings growth (last year)-300.00%
Earnings growth (this year)+104.76%
Earnings growth (next 5 years)+20.00%
Revenue growth (last year)+14.62%
P/E ratioNM
Price/Sales4.77
Price/Book3.35

Competitors

 Today’s
change
Today’s
% change
FMIFoundation Medicine ...-0.09-0.41%
GHDXGenomic Health Inc-0.38-1.35%
GNMKGenMark Diagnostics ...-0.14-1.43%
RDNTRadNet Inc-0.09-1.52%
Data as of 07/25/2016

Financials

Last reporting dateJuly 18, 2016
EPS forecast (this quarter)$0.03
Annual revenue (last year)$99.8M
Annual profit (last year)-$2.5M
Net profit margin-2.54%

Profile

Sector
Health Services
Industry
Medical/Nursing Services
Executive Chairman &
Chief Executive Officer
Douglas M. Van Oort
Vice President-
Operations
Mark Machulcz
Corporate headquarters
Fort Myers, Florida

Forecasts

Partner Offers

Search for Jobs